United States Hemoperfusion Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Hemoperfusion Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Hemoperfusion Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Hemoperfusion Overall Market Size
2.1 United States Hemoperfusion Market Size: 2021 VS 2027
2.2 United States Hemoperfusion Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Hemoperfusion Sales: 2016-2027
3 Company Landscape
3.1 Top Hemoperfusion Players in United States Market
3.2 Top United States Hemoperfusion Companies Ranked by Revenue
3.3 United States Hemoperfusion Revenue by Companies
3.4 United States Hemoperfusion Sales by Companies
3.5 United States Hemoperfusion Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hemoperfusion Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Hemoperfusion Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hemoperfusion Players in United States Market
3.8.1 List of Tier 1 Hemoperfusion Companies in United States
3.8.2 List of Tier 2 and Tier 3 Hemoperfusion Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Hemoperfusion Market Size Markets, 2021 & 2027
4.1.2 Activated Carbon Adsorption
4.1.3 Resin Adsorption
4.2 By Type - United States Hemoperfusion Revenue & Forecasts
4.2.1 By Type - United States Hemoperfusion Revenue, 2016-2021
4.2.2 By Type - United States Hemoperfusion Revenue, 2022-2027
4.2.3 By Type - United States Hemoperfusion Revenue Market Share, 2016-2027
4.3 By Type - United States Hemoperfusion Sales & Forecasts
4.3.1 By Type - United States Hemoperfusion Sales, 2016-2021
4.3.2 By Type - United States Hemoperfusion Sales, 2022-2027
4.3.3 By Type - United States Hemoperfusion Sales Market Share, 2016-2027
4.4 By Type - United States Hemoperfusion Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Hemoperfusion Market Size, 2021 & 2027
5.1.2 Hepatic Encephalopathy
5.1.3 Certain Autoimmune Diseases
5.1.4 Drug Overdose
5.1.5 Specific Intoxications
5.1.6 Others
5.2 By Application - United States Hemoperfusion Revenue & Forecasts
5.2.1 By Application - United States Hemoperfusion Revenue, 2016-2021
5.2.2 By Application - United States Hemoperfusion Revenue, 2022-2027
5.2.3 By Application - United States Hemoperfusion Revenue Market Share, 2016-2027
5.3 By Application - United States Hemoperfusion Sales & Forecasts
5.3.1 By Application - United States Hemoperfusion Sales, 2016-2021
5.3.2 By Application - United States Hemoperfusion Sales, 2022-2027
5.3.3 By Application - United States Hemoperfusion Sales Market Share, 2016-2027
5.4 By Application - United States Hemoperfusion Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Jafron Biomedical
6.1.1 Jafron Biomedical Corporation Information
6.1.2 Jafron Biomedical Overview
6.1.3 Jafron Biomedical Hemoperfusion Sales and Revenue in United States Market (2016-2021)
6.1.4 Jafron Biomedical Hemoperfusion Product Description
6.1.5 Jafron Biomedical Recent Developments
6.2 Baxter (Gambro)
6.2.1 Baxter (Gambro) Corporation Information
6.2.2 Baxter (Gambro) Overview
6.2.3 Baxter (Gambro) Hemoperfusion Sales and Revenue in United States Market (2016-2021)
6.2.4 Baxter (Gambro) Hemoperfusion Product Description
6.2.5 Baxter (Gambro) Recent Developments
6.3 Asahi-Kasei
6.3.1 Asahi-Kasei Corporation Information
6.3.2 Asahi-Kasei Overview
6.3.3 Asahi-Kasei Hemoperfusion Sales and Revenue in United States Market (2016-2021)
6.3.4 Asahi-Kasei Hemoperfusion Product Description
6.3.5 Asahi-Kasei Recent Developments
6.4 Biosun Medical
6.4.1 Biosun Medical Corporation Information
6.4.2 Biosun Medical Overview
6.4.3 Biosun Medical Hemoperfusion Sales and Revenue in United States Market (2016-2021)
6.4.4 Biosun Medical Hemoperfusion Product Description
6.4.5 Biosun Medical Recent Developments
6.5 Kaneka
6.5.1 Kaneka Corporation Information
6.5.2 Kaneka Overview
6.5.3 Kaneka Hemoperfusion Sales and Revenue in United States Market (2016-2021)
6.5.4 Kaneka Hemoperfusion Product Description
6.5.5 Kaneka Recent Developments
6.6 Toray Medical
6.6.1 Toray Medical Corporation Information
6.6.2 Toray Medical Overview
6.6.3 Toray Medical Hemoperfusion Sales and Revenue in United States Market (2016-2021)
6.6.4 Toray Medical Hemoperfusion Product Description
6.6.5 Toray Medical Recent Developments
6.7 Cytosorbents
6.7.1 Cytosorbents Corporation Information
6.7.2 Cytosorbents Overview
6.7.3 Cytosorbents Hemoperfusion Sales and Revenue in United States Market (2016-2021)
6.7.4 Cytosorbents Hemoperfusion Product Description
6.7.5 Cytosorbents Recent Developments
6.8 Aier
6.8.1 Aier Corporation Information
6.8.2 Aier Overview
6.8.3 Aier Hemoperfusion Sales and Revenue in United States Market (2016-2021)
6.8.4 Aier Hemoperfusion Product Description
6.8.5 Aier Recent Developments
6.9 Zibo Kangbei
6.9.1 Zibo Kangbei Corporation Information
6.9.2 Zibo Kangbei Overview
6.9.3 Zibo Kangbei Hemoperfusion Sales and Revenue in United States Market (2016-2021)
6.9.4 Zibo Kangbei Hemoperfusion Product Description
6.9.5 Zibo Kangbei Recent Developments
7 United States Hemoperfusion Production Capacity, Analysis
7.1 United States Hemoperfusion Production Capacity, 2016-2027
7.2 Hemoperfusion Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Hemoperfusion Supply Chain Analysis
9.1 Hemoperfusion Industry Value Chain
9.2 Hemoperfusion Upstream Market
9.3 Hemoperfusion Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Hemoperfusion Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Hemoperfusion in United States Market
Table 2. Top Hemoperfusion Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Hemoperfusion Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Hemoperfusion Revenue Share by Companies, 2016-2021
Table 5. United States Hemoperfusion Sales by Companies, (K Units), 2016-2021
Table 6. United States Hemoperfusion Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hemoperfusion Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Hemoperfusion Product Type
Table 9. List of Tier 1 Hemoperfusion Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Hemoperfusion Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Activated Carbon Adsorption
Table 12. Major Manufacturers of Resin Adsorption
Table 13. By Type - United States Hemoperfusion Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Hemoperfusion Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Hemoperfusion Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Hemoperfusion Sales (K Units), 2016-2021
Table 17. By Type - United States Hemoperfusion Sales (K Units), 2022-2027
Table 18. By Application - United States Hemoperfusion Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Hemoperfusion Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Hemoperfusion Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Hemoperfusion Sales (K Units), 2016-2021
Table 22. By Application - United States Hemoperfusion Sales (K Units), 2022-2027
Table 23. Jafron Biomedical Corporation Information
Table 24. Jafron Biomedical Description and Major Businesses
Table 25. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Jafron Biomedical Hemoperfusion Product
Table 27. Jafron Biomedical Recent Developments
Table 28. Baxter (Gambro) Corporation Information
Table 29. Baxter (Gambro) Description and Major Businesses
Table 30. Baxter (Gambro) Hemoperfusion Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Baxter (Gambro) Hemoperfusion Product
Table 32. Baxter (Gambro) Recent Developments
Table 33. Asahi-Kasei Corporation Information
Table 34. Asahi-Kasei Description and Major Businesses
Table 35. Asahi-Kasei Hemoperfusion Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Asahi-Kasei Hemoperfusion Product
Table 37. Asahi-Kasei Recent Developments
Table 38. Biosun Medical Corporation Information
Table 39. Biosun Medical Description and Major Businesses
Table 40. Biosun Medical Hemoperfusion Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Biosun Medical Hemoperfusion Product
Table 42. Biosun Medical Recent Developments
Table 43. Kaneka Corporation Information
Table 44. Kaneka Description and Major Businesses
Table 45. Kaneka Hemoperfusion Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Kaneka Hemoperfusion Product
Table 47. Kaneka Recent Developments
Table 48. Toray Medical Corporation Information
Table 49. Toray Medical Description and Major Businesses
Table 50. Toray Medical Hemoperfusion Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Toray Medical Hemoperfusion Product
Table 52. Toray Medical Recent Developments
Table 53. Cytosorbents Corporation Information
Table 54. Cytosorbents Description and Major Businesses
Table 55. Cytosorbents Hemoperfusion Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Cytosorbents Hemoperfusion Product
Table 57. Cytosorbents Recent Developments
Table 58. Aier Corporation Information
Table 59. Aier Description and Major Businesses
Table 60. Aier Hemoperfusion Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Aier Hemoperfusion Product
Table 62. Aier Recent Developments
Table 63. Zibo Kangbei Corporation Information
Table 64. Zibo Kangbei Description and Major Businesses
Table 65. Zibo Kangbei Hemoperfusion Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Zibo Kangbei Hemoperfusion Product
Table 67. Zibo Kangbei Recent Developments
Table 68. Hemoperfusion Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 69. United States Hemoperfusion Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Hemoperfusion Market Opportunities & Trends in United States Market
Table 71. Hemoperfusion Market Drivers in United States Market
Table 72. Hemoperfusion Market Restraints in United States Market
Table 73. Hemoperfusion Raw Materials
Table 74. Hemoperfusion Raw Materials Suppliers in United States Market
Table 75. Typical Hemoperfusion Downstream
Table 76. Hemoperfusion Downstream Clients in United States Market
Table 77. Hemoperfusion Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Hemoperfusion Product Picture
Figure 2. Hemoperfusion Segment by Type
Figure 3. Hemoperfusion Segment by Application
Figure 4. United States Hemoperfusion Market Overview: 2020
Figure 5. United States Hemoperfusion Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Hemoperfusion Revenue, 2016-2027 (US$, Mn)
Figure 7. Hemoperfusion Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hemoperfusion Revenue in 2020
Figure 9. Activated Carbon Adsorption Product Picture
Figure 10. Resin Adsorption Product Picture
Figure 11. By Type - United States Hemoperfusion Sales Market Share, 2016-2027
Figure 12. By Type - United States Hemoperfusion Revenue Market Share, 2016-2027
Figure 13. By Type - United States Hemoperfusion Price (USD/Unit), 2016-2027
Figure 14. Hepatic Encephalopathy
Figure 15. Certain Autoimmune Diseases
Figure 16. Drug Overdose
Figure 17. Specific Intoxications
Figure 18. Others
Figure 19. By Application - United States Hemoperfusion Sales Market Share, 2016-2027
Figure 20. By Application - United States Hemoperfusion Revenue Market Share, 2016-2027
Figure 21. By Application - United States Hemoperfusion Price (USD/Unit), 2016-2027
Figure 22. Jafron Biomedical Hemoperfusion Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Baxter (Gambro) Hemoperfusion Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Asahi-Kasei Hemoperfusion Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Biosun Medical Hemoperfusion Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Kaneka Hemoperfusion Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Toray Medical Hemoperfusion Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Cytosorbents Hemoperfusion Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Aier Hemoperfusion Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Zibo Kangbei Hemoperfusion Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. United States Hemoperfusion Production Capacity (K Units), 2016-2027
Figure 32. Hemoperfusion Industry Value Chain
Figure 33. Marketing Channels